This is a competitive renewal application from the University of Maryland and the University of Bamako, Mali for continued support for a successful Global Infectious Diseases Research Training Program (GIDRTP), Malaria Research Training in Mali. The overall goal of the program is to build sustainable research capacity at the Malaria Research and Training Center (MRTC) at the University of Bamako, Mali. This will be accomplished by continuing to provide malaria research training to junior and now mid-career scientists at the MRTC, filling identified gaps in expertise and capacity at the MRTC, and strengthening the sustainability of malaria research in Mali by developing the ability of MRTC scientists to compete for external research funding. The ultimate result of this training will be to benefit the public health of Mali by strengthening the country's capacity to conduct relevant biomedical research and translate the results of this research into public health tools and policies. The University of Maryland and the University of Bamako have worked in close partnership for 15 years on studies of malaria drug resistance, pathogenesis, immunity, epidemiology, genetics and clinical trials of vaccines and drugs. Since 2005, the scientific core of this collaboration has been provided by an International Collaborations in Infectious Disease Research (ICIDR) grant from NIAID to the University of Maryland and University of Bamako. This successful research partnership has helped create a rich environment for training Malian malaria researchers. The GIDRTP has provided opportunities for dozens of MRTC scientists, including short-term training in the U.S., Europe and Mali, and long-term degree training based both in Mali and in the U.S. The most senior and accomplished of the original Malaria Training Grant trainees has assumed the role of Major Foreign Collaborator on the ICIDR and Mali Program Director on this completing renewal application, providing direct evidence of the training grant's effectiveness. We propose to maintain and extend this successful training program, strengthening a bioinformatics component emphasizing applied human and parasite genomics, genomic epidemiology and evolutionary genetics research. To meet the needs of the MRTC to develop in-house expertise in these fields, including the ability to manage and analyze genomic-scale datasets, one MRTC researcher will undertake PhD training in evolutionary genetics at the University of Pennsylvania Department of Genetics and one in the University of Maryland's Molecular Epidemiology Track in the Department of Epidemiology and Public Health.

Public Health Relevance

STATEMENT The overall goal of our research training program is to build sustainable malaria research capacity at the Malaria Research and Training Center (MRTC) at the University of Bamako, Mali. This will be accomplished by continuing to provide training in malaria research to junior and mid-career scientists at the MRTC, filling identified gaps in expertise and capacity at the MRTC, and strengthening the sustainability of malaria research in Mali by developing the ability of MRTC scientists to compete for external research funding. The ultimate result of this training will be to benefit the public health of Mali by strengthening the country's capacity to conduct relevant biomedical research and translate the results of this research into public health tools and policies.

Agency
National Institute of Health (NIH)
Type
International Research Training Grants (D43)
Project #
5D43TW001589-14
Application #
8705070
Study Section
Special Emphasis Panel (ZRG1)
Program Officer
Sina, Barbara J
Project Start
Project End
Budget Start
Budget End
Support Year
14
Fiscal Year
2014
Total Cost
Indirect Cost
Name
University of Maryland Baltimore
Department
None
Type
Schools of Medicine
DUNS #
City
Baltimore
State
MD
Country
United States
Zip Code
21201
Coulibaly, Drissa; Travassos, Mark A; Kone, Abdoulaye K et al. (2014) Stable malaria incidence despite scaling up control strategies in a malaria vaccine-testing site in Mali. Malar J 13:374
Gandhi, Kavita; Thera, Mahamadou A; Coulibaly, Drissa et al. (2014) Variation in the circumsporozoite protein of Plasmodium falciparum: vaccine development implications. PLoS One 9:e101783
Ouattara, Amed; Takala-Harrison, Shannon; Thera, Mahamadou A et al. (2013) Molecular basis of allele-specific efficacy of a blood-stage malaria vaccine: vaccine development implications. J Infect Dis 207:511-9
Coulibaly, Drissa; Rebaudet, Stanislas; Travassos, Mark et al. (2013) Spatio-temporal analysis of malaria within a transmission season in Bandiagara, Mali. Malar J 12:82
Thera, Mahamadou A; Plowe, Christopher V (2012) Vaccines for malaria: how close are we? Annu Rev Med 63:345-57
Thera, Mahamadou A; Doumbo, Ogobara K; Coulibaly, Drissa et al. (2011) A field trial to assess a blood-stage malaria vaccine. N Engl J Med 365:1004-13
Thera, Mahamadou A; Doumbo, Ogobara K; Coulibaly, Drissa et al. (2010) Safety and immunogenicity of an AMA1 malaria vaccine in Malian children: results of a phase 1 randomized controlled trial. PLoS One 5:e9041
Kone, Abdoulaye K; Sagara, Issaka; Thera, Mahamadou A et al. (2010) Plasmodium falciparum clearance with artemisinin-based combination therapy (ACT) in patients with glucose-6-phosphate dehydrogenase deficiency in Mali. Malar J 9:332
Kone, Aminatou; van de Vegte-Bolmer, Marga; Siebelink-Stoter, Rianne et al. (2010) Sulfadoxine-pyrimethamine impairs Plasmodium falciparum gametocyte infectivity and Anopheles mosquito survival. Int J Parasitol 40:1221-8
Doumbo, Ogobara K; Thera, Mahamadou A; Kone, Abdoulaye K et al. (2009) High levels of Plasmodium falciparum rosetting in all clinical forms of severe malaria in African children. Am J Trop Med Hyg 81:987-93

Showing the most recent 10 out of 19 publications